| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | -13.9% |
| Cost of Revenue | $200K | +100.0% |
| Gross Profit | $8.3M | -17.4% |
| R&D Expense | $100K | -50.0% |
| SG&A Expense | $22.5M | -22.6% |
| Operating Income | -$17.3M | +30.9% |
| Pre-tax Income | -$13.6M | +43.0% |
| Net Income | -$13.6M | +43.0% |
| EPS (Basic) | -$11.14 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -53.3% |
| Accounts Receivable | $202K | -55.8% |
| Current Assets | $2.5M | -54.6% |
| Total Assets | $10.7M | -21.8% |
| Current Liabilities | $7.3M | +7.0% |
| Long-term Debt | $1.2M | — |
| Total Liabilities | $10.3M | +15.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.9M | +39.0% |
| Capital Expenditures | $803K | -13.1% |
| Investing Cash Flow | -$853K | +7.7% |
| Financing Cash Flow | $10.9M | — |
| Free Cash Flow | -$12.7M | +37.8% |
| -971.2% |
| EPS (Diluted) | -$11.14 | +57.0% |
| Stockholders' Equity |
| $411K |
| -91.4% |